These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28189846)

  • 1. Isolevuglandins as a gauge of lipid peroxidation in human tumors.
    Yan HP; Roberts LJ; Davies SS; Pohlmann P; Parl FF; Estes S; Maeng J; Parker B; Mernaugh R
    Free Radic Biol Med; 2017 May; 106():62-68. PubMed ID: 28189846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.
    Longato L; Andreola F; Davies SS; Roberts JL; Fusai G; Pinzani M; Moore K; Rombouts K
    Free Radic Biol Med; 2017 Jan; 102():162-173. PubMed ID: 27890721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolevuglandin adducts in disease.
    Salomon RG; Bi W
    Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
    Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
    Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
    Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
    Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
    Salomon RG
    Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo.
    Poliakov E; Brennan ML; Macpherson J; Zhang R; Sha W; Narine L; Salomon RG; Hazen SL
    FASEB J; 2003 Dec; 17(15):2209-20. PubMed ID: 14656983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
    Roberts LJ; Salomon RG; Morrow JD; Brame CJ
    FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized phospholipids, isolevuglandins, and atherosclerosis.
    Zhang W; Salomon RG
    Mol Nutr Food Res; 2005 Nov; 49(11):1050-62. PubMed ID: 16270278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Detection of Isolevuglandins in Tissues using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence.
    Warden C; Simmons AJ; Pasic L; Pitzer A; Davies SS; Layer JH; Mernaugh RL; Kirabo A
    J Vis Exp; 2021 Jul; (173):. PubMed ID: 34279509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes.
    Subati T; Yang Z; Murphy MB; Stark JM; Trykall DZ; Davies SS; Barnett JV; Murray KT
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria.
    Zhong H; Yin H
    Redox Biol; 2015; 4():193-9. PubMed ID: 25598486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis.
    Salomon RG
    Ann N Y Acad Sci; 2005 Jun; 1043():327-42. PubMed ID: 16037255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.
    Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG
    Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway.
    Salomon RG; Batyreva E; Kaur K; Sprecher DL; Schreiber MJ; Crabb JW; Penn MS; DiCorletoe AM; Hazen SL; Podrez EA
    Biochim Biophys Acta; 2000 May; 1485(2-3):225-35. PubMed ID: 10832102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
    Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
    Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells.
    Maulucci G; Daniel B; Cohen O; Avrahami Y; Sasson S
    Mol Aspects Med; 2016 Jun; 49():49-77. PubMed ID: 27012748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Processes of free radical lipid peroxidation with a particular regard to the role of paraoxonase-1 in the pathogenesis of multiple sclerosis].
    Berbecki J; Mitosek-Szewczyk K; Kurzepa J; Nastaj M; Łobejko K; Stelmasiak Z
    Wiad Lek; 2011; 64(1):31-6. PubMed ID: 21812361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive aldehydes--second messengers of free radicals in diabetes mellitus.
    Jaganjac M; Tirosh O; Cohen G; Sasson S; Zarkovic N
    Free Radic Res; 2013 Aug; 47 Suppl 1():39-48. PubMed ID: 23521622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.